Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Omega Bio-Tek Inc. has one pending office action in Biotechnology & Pharmaceuticals. One examiner and one art unit are associated with the matter. KAPUSHOC, STEPHEN THOMAS is the busiest examiner, with one pending matter, so the active prosecution record is concentrated in one examination relationship.
The available data supports a targeted response to the pending action, with attention to the assigned biotechnology and pharmaceutical art unit. No additional examiner or art-unit assignments appear. Counsel can focus on the specific claim issues, technical support, and examiner interaction needed for the single active matter.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KAPUSHOC, STEPHEN THOMAS | 1 | 46.5% | +53.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18429891 | Method of Purifying Nucleic Acids Using Modified Solid Phases | KAPUSHOC, STEPHEN THOMAS | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18429891 | Method of Purifying Nucleic Acids Using Modified Solid Phases | KAPUSHOC, STEPHEN THOMAS | — |
| Art Unit | Apps |
|---|---|
| 1683 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18429891 | Method of Purifying Nucleic Acids Using Modified Solid Phases | KAPUSHOC, STEPHEN THOMAS | 1683 | §102§103§112 | Non-Final OA | — | Pending | Feb 01, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialOmega Bio-Tek Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Stephen Thomas Kapushoc has the most, with 1 of Omega Bio-Tek Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
